Starting With a Lower Daily Dose of Dasatinib in Patients With Chronic Myeloid Leukemia in Chronic Phase: Less Is More, or Is It?
Cancer - United States
doi 10.1002/cncr.31682
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Wiley